Free APRI Calculator

The APRI Score: A Noninvasive Marker of Liver Fibrosis

The AST to Platelet Ratio Index (APRI) is a hepatic fibrosis calculator widely used to predict liver fibrosis and cirrhosis without the need for invasive procedures. By combining two routine laboratory parameters—aspartate aminotransferase (AST) and platelet count—this cirrhosis assessment tool yields a score that helps clinicians gauge the extent of liver scarring. Initially validated in patients with chronic hepatitis C, the APRI has since been applied to other common fibrotic liver diseases, making it a versatile liver fibrosis score.

How to Calculate the APRI Score

The APRI calculation requires three values:

• AST level – the patient’s serum AST measured in international units per liter (IU/L).
• AST upper limit of normal (ULN) – a reference standard that can be adjusted; the default value is 40 IU/L.
• Platelet count – expressed in $10^{9}/\text{L}$.

The formula is:

$$\text{APRI} = \frac{ \frac{\text{AST level}}{\text{AST ULN}} }{ \text{Platelet count} } \times 100$$

This double ratio standardizes the AST elevation relative to the normal range and relates it to the platelet count.

Interpreting the APRI Results

Systematic reviews have established specific cutoffs for fibrosis staging:

• Significant fibrosis: APRI ≥ 0.7 (sensitivity 77 %, specificity 72 %)
• Severe fibrosis: APRI ≥ 1.0 (sensitivity 61 %, specificity 64 %)
• Cirrhosis: APRI ≥ 1.0 (sensitivity 76 %, specificity 72 %)

Sensitivity measures the proportion of patients with the condition who are correctly identified; specificity measures the proportion without the condition who are correctly excluded. These performance data come from the meta‑analysis Performance of the Aspartate Aminotransferase‑To‑Platelet Ratio Index for the Staging of Hepatitis C‑related Fibrosis.

APRI also supports clinical decision‑making:

• A score below 0.5 carries a high negative predictive value, effectively ruling out cirrhosis.
• A score above 1.5 carries a high positive predictive value, effectively ruling in cirrhosis.

These thresholds are drawn from the systematic review Blood Tests to Diagnose Fibrosis or Cirrhosis in Patients With Chronic Hepatitis C Virus Infection.

Worked Example

Take a patient with the following labs:

• AST: 110 IU/L
• AST ULN: 40 IU/L (default)
• Platelet count: $110 \times 10^{9}/\text{L}$

Calculation:

$$\text{APRI} = \frac{ \frac{110}{40} }{ 110 } \times 100 = \frac{2.75}{110} \times 100 = 0.025 \times 100 = 2.5$$

An APRI of 2.5 exceeds the 1.0 cirrhosis threshold, indicating that the patient likely has severe fibrosis or cirrhosis.

Important Considerations

Although the APRI calculator offers a quick, noninvasive estimate, it is not a substitute for a physician’s judgment. Results should be interpreted alongside the patient’s history, physical exam, and additional imaging or laboratory tests. The calculator is most reliable when the AST ULN matches the laboratory’s own reference range. Given its reliance on basic blood tests, the APRI is a cost‑effective first‑line option for monitoring disease progression over time.